Foreign Firms To Cut Prices In Hungary

16 June 1996

Zsuzsanna Matejka, chief pharmacist at Hungary's National Health Fund, says about 20 foreign firms are shortly to cut the prices of 150-200 drugs by 15%-20% on average, reports MTI Econews. The reductions will mainly affect drugs which face competition or have high prices.

Prices of 300 foreign drugs were cut in 1995, but the forint's devaluation and the temporary import surcharge had cancelled this out by the time the drugs reached the consumer, said Ms Matejka.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight